Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
3,260 JPY | +1.56% | +4.32% | +4.65% |
Jun. 17 | Taiyo Holdings Appoints Former J&J Exec as Chairman | MT |
May. 08 | Taiyo Yuden's Attributable Profit up or down 64% in Fiscal 2024 | MT |
Business Summary
Number of employees: 2,120
Sales per Business
JPY in Million | 2023 | Weight | 2024 | Weight | Delta |
---|---|---|---|---|---|
Electronics
68.2
%
| 68,419 | 70.3 % | 71,415 | 68.2 % | +4.38% |
Medical and Pharmaceutical
27.9
%
| 25,447 | 26.1 % | 29,269 | 27.9 % | +15.02% |
Others
3.9
%
| 3,472 | 3.6 % | 4,090 | 3.9 % | +17.80% |
Sales per region
JPY in Million | 2023 | Weight | 2024 | Weight | Delta |
---|---|---|---|---|---|
China
38.2
%
| 34,378 | 35.3 % | 39,987 | 38.2 % | +16.32% |
Japan
35.8
%
| 33,885 | 34.8 % | 37,459 | 35.8 % | +10.55% |
South Korea
13.4
%
| 15,810 | 16.2 % | 14,087 | 13.4 % | -10.90% |
Taiwan
6.7
%
| 7,328 | 7.5 % | 6,995 | 6.7 % | -4.54% |
Others
6.0
%
| 5,936 | 6.1 % | 6,245 | 6.0 % | +5.21% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Eiji Sato
CEO | Chief Executive Officer | 55 | 08-05-31 |
Shoji Minegishi
CTO | Chief Tech/Sci/R&D Officer | - | - |
Hitoshi Saito
BRD | Director/Board Member | 59 | 96-08-31 |
Masayuki Hizume
BRD | Director/Board Member | 61 | 94-05-31 |
Shuichi Omi
IRC | Investor Relations Contact | - | - |
Kaori Terunuma
AUD | Comptroller/Controller/Auditor | - | - |
General Counsel | - | - | |
Takuji Maekawa
PRN | Corporate Officer/Principal | - | 19-06-05 |
Masaru Ohki
AUD | Comptroller/Controller/Auditor | 66 | 82-07-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Eiji Sato
CEO | Chief Executive Officer | 55 | 08-05-31 |
Tomoyuki Tanaka
BRD | Director/Board Member | - | - |
Masayuki Hizume
BRD | Director/Board Member | 61 | 94-05-31 |
Hitoshi Saito
BRD | Director/Board Member | 59 | 96-08-31 |
Keiko Tsuchiya
BRD | Director/Board Member | 64 | 17-05-31 |
Asako Aoyama
BRD | Director/Board Member | - | - |
Yumiko Kamada
BRD | Director/Board Member | 58 | - |
Masao Arima
BRD | Director/Board Member | - | - |
Tomoyuki Tanaka
BRD | Director/Board Member | - | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 58,291,559 | 38,409,121 ( 65.89 %) | 2,366,038 ( 4.059 %) | 65.89 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
TAIYO HOLDINGS CO., LTD. 4.06% | 2,366,038 | 4.06% | 48,632,184 $ |
CYFUSE BIOMEDICAL K.K. 3.69% | 300,000 | 3.69% | 1,420,344 $ |
Company contact information
Taiyo Holdings Co., Ltd.
Metropolitan Plaza Bldg., 16/F 1-11-1 Nishiikebukuro
171-0021, Tokyo
+
http://www.taiyo-hd.co.jpSales per Business
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+3.05% | 1.15B | |
+22.61% | 68.55B | |
-7.16% | 46.06B | |
+23.71% | 44.48B | |
+28.88% | 28.5B | |
+6.83% | 19.22B | |
-26.60% | 15.27B | |
-10.31% | 15.22B | |
-30.35% | 12.17B | |
-29.96% | 12.12B |
- Stock Market
- Equities
- 4626 Stock
- Company Taiyo Holdings Co., Ltd.